Skip to content
Open access · OA via OpenAlex

Metformin: Do we finally have an anti-aging drug?

Vladimir N. Anisimov

Cell Cycle · 2013 · ▲ 117 citations

Abstract

Studies in mammals have demonstrated that hyperglycemia and hyperinsulinemia are important factors in aging and cancer. Inactivation of insulin/insulin-like signaling increases lifespan in nematodes, fruit flies, and mice. Life-prolonging effects of caloric restriction(definition) are in part due to reduction in IGF-1, insulin, and glucose levels. Antidiabetic biguanides such as metformin, which reduce hyperglycemia and hyperinsulinemia by decreasing insulin resistance, extend lifespan, and inhibit carcinogenesis in rodents. Will antidiabetic biguanides increase lifespan in humans?

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.4161/cc.26928
Canonical
link ↗
Fetched
2026-08-07 MST

Cite this

APA
Anisimov, V.N. (2013). Metformin: Do we finally have an anti-aging drug?. <em>Cell Cycle</em>. https://doi.org/10.4161/cc.26928
Vancouver
Anisimov VN. Metformin: Do we finally have an anti-aging drug?. Cell Cycle. 2013. doi:10.4161/cc.26928.
BibTeX
@article{vladimir2013Metfor, title = {Metformin: Do we finally have an anti-aging drug?}, author = {Vladimir N. Anisimov}, journal = {Cell Cycle}, year = {2013}, doi = {10.4161/cc.26928}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings